Literature DB >> 11857317

Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas.

Ewa Filipowicz1, P Adegboyega, R L Sanchez, Zoran Gatalica.   

Abstract

BACKGROUND: Carcinomas of the skin are by far the most common human malignancies. Continuous exposure to ultraviolet (UV) light facilitates the development of precancerous lesions (actinic keratosis [AK]) that may progress to invasive squamous carcinomas. Apoptosis, triggered by the activation of CD95 (Fas), is one of the most important defense mechanisms against UV light-induced carcinogenesis in experimental models, but the dynamics of CD95 expression in patients with sun-induced lesions are largely unknown.
METHODS: The authors studied the expression of CD95 (Fas) in biopsy samples of normal skin (not exposed to sun) and compared it with chronically sun-exposed skin (as evidenced by solar elastosis), AK, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), and keratoacanthomas (KA).
RESULTS: Normal skin keratinocytes expressed CD95 in cytoplasmic membranes and intercellular bridges in the basal layer. In chronically sun-exposed keratinocytes (solar elastosis, no evidence of dysplasia), CD95 expression was up-regulated and was observed throughout the entire thickness of the epidermis. However, in actinic keratosis there was a complete absence of Fas in approximately two-thirds of the cases (8 of 12). In invasive SCC, CD95 was expressed focally and weakly only at the sites of contact with stromal lymphocytes. Keratoacanthomas consistently expressed CD95 at the interface with the inflammatory cells. No staining was observed in BCC.
CONCLUSIONS: CD95 (Fas) up-regulation in chronically sun-exposed keratinocytes indicates an important role in the control of sun-induced damage. Further sun exposure results, however, in significant down-regulation of this defense mechanism, proportional to the degree of dysplasia. Copyright 2002 American Cancer Society. DOI 10.1002/cncr.10277

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857317     DOI: 10.1002/cncr.10277

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.

Authors:  Wusheng Yan; Ignacio I Wistuba; Michael R Emmert-Buck; Heidi S Erickson
Journal:  Am J Cancer Res       Date:  2011-01-01       Impact factor: 6.166

2.  Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach.

Authors:  James Q Del Rosso; Leon Kircik; Gary Goldenberg; Berman Brian
Journal:  J Clin Aesthet Dermatol       Date:  2014-09

3.  Wogonoside Attenuates Cutaneous Squamous Cell Carcinoma by Reducing Epithelial-Mesenchymal Transition/Invasion and Cancer Stem-Like Cell Property.

Authors:  Xiuyong Wang; Yuan Chang; Ming Gao; Fan Zhang
Journal:  Onco Targets Ther       Date:  2020-10-09       Impact factor: 4.147

4.  Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer.

Authors:  Ke Yao; Hanyong Chen; Kangdong Liu; Alyssa Langfald; Ge Yang; Yi Zhang; Dong Hoon Yu; Myoung Ok Kim; Mee-Hyun Lee; Haitao Li; Ki Beom Bae; Hong-Gyum Kim; Wei-Ya Ma; Ann M Bode; Ziming Dong; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-03

5.  Acitretin induces apoptosis through CD95 signalling pathway in human cutaneous squamous cell carcinoma cell line SCL-1.

Authors:  Xiu-Ying Lin; Chun-Di He; Ting Xiao; Xin Jin; Jiang Chen; Ya-Kun Wang; Mei Liu; Kai-Bo Wang; Yi Jiang; Hua-Chen Wei; Hong-Duo Chen
Journal:  J Cell Mol Med       Date:  2009-06-20       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.